Publicaciones en colaboración con investigadores/as de Instituto de Investigación Biomédica de Salamanca (2)

2018

  1. Correction: Mutations in the DNA methylation pathway and number of driver mutations predict response to azacitidine in myelodysplastic syndromes [Oncotarget, 8 (2017) (106948-106961)] DOI: 10.18632/oncotarget.22157

    Oncotarget

2017

  1. Mutations in the DNA methylation pathway and number of driver mutations predict response to azacitidine in myelodysplastic syndromes

    Oncotarget, Vol. 8, Núm. 63, pp. 106948-106961